A business in context
IOVA research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-08 | Vogt Frederick G | M · Exercise / conversion | Common Stock | 15626.0 | 0.0 |
| 2026-09-08 | Vogt Frederick G | F · Tax / exercise payment | Common Stock | 6638.0 | 8.7 |
| 2026-09-08 | Vogt Frederick G | M · Exercise / conversion | Restricted Stock Units | 15626.0 | 0.0 |
| 2026-09-08 | BILINSKY IGOR | M · Exercise / conversion | Common Stock | 7813.0 | 0.0 |
| 2026-09-08 | BILINSKY IGOR | F · Tax / exercise payment | Common Stock | 3976.0 | 8.7 |
| 2026-09-08 | BILINSKY IGOR | M · Exercise / conversion | Restricted Stock Units | 7813.0 | 0.0 |
| 2026-09-08 | Puri Raj K. | F · Tax / exercise payment | Common Stock | 4478.0 | 8.7 |
| 2026-09-08 | Puri Raj K. | M · Exercise / conversion | Common Stock | 9766.0 | 0.0 |
| 2026-09-08 | Puri Raj K. | M · Exercise / conversion | Restricted Stock Units | 9766.0 | 0.0 |
| 2026-09-01 | Vogt Frederick G | M · Exercise / conversion | Common Stock | 41669.0 | 0.0 |
| 2026-09-01 | Vogt Frederick G | F · Tax / exercise payment | Common Stock | 17702.0 | 8.28 |
| 2026-09-01 | Vogt Frederick G | M · Exercise / conversion | Restricted Stock Units | 41669.0 | 0.0 |
| 2026-09-01 | Puri Raj K. | M · Exercise / conversion | Common Stock | 5470.0 | 0.0 |
| 2026-09-01 | Puri Raj K. | F · Tax / exercise payment | Common Stock | 2508.0 | 8.28 |
| 2026-09-01 | Puri Raj K. | M · Exercise / conversion | Restricted Stock Units | 5470.0 | 0.0 |
| 2026-09-01 | BILINSKY IGOR | M · Exercise / conversion | Common Stock | 8789.0 | 0.0 |
| 2026-09-01 | BILINSKY IGOR | F · Tax / exercise payment | Common Stock | 4472.0 | 8.28 |
| 2026-09-01 | BILINSKY IGOR | M · Exercise / conversion | Restricted Stock Units | 8789.0 | 0.0 |
| 2026-08-10 | Kirby Daniel Gordon | M · Exercise / conversion | Common Stock | 10001.0 | 0.0 |
| 2026-08-10 | Kirby Daniel Gordon | F · Tax / exercise payment | Common Stock | 2436.0 | 6.4 |
| 2026-08-10 | Kirby Daniel Gordon | M · Exercise / conversion | Restricted Stock Units | 10001.0 | 0.0 |
| 2026-08-06 | Roche Corleen M. | F · Tax / exercise payment | Common Stock | 21238.0 | 6.21 |
| 2026-08-06 | Roche Corleen M. | M · Exercise / conversion | Common Stock | 49995.0 | 0.0 |
| 2026-08-06 | Roche Corleen M. | M · Exercise / conversion | Restricted Stock Units | 49995.0 | 0.0 |
Identity & relationships
SEC issuer · 0001425205IOVANCE BIOTHERAPEUTICS, INC.
Search names and former names
View Wikidata identity and references ↗
- Iovance Biotherapeutics · alias · wikidata
- Lion Biotechnologies, Inc. · former SEC name · 2013-10-23 to 2017-06-05
- Genesis Biopharma, Inc · former SEC name · 2010-03-19 to 2013-09-23
- FREIGHT MANAGEMENT CORP · former SEC name · 2008-01-29 to 2010-03-08
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $164.07M | $176.23M |
| 2023-12-31 | $1.19M | $1.31M |